Literature DB >> 10708447

Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations.

J S Harms1, X Ren, S C Oliveira, G A Splitter.   

Abstract

The alphaherpesvirus tegument protein VP22 has been characterized with multiple traits including microtubule reorganization, nuclear localization, and nonclassical intercellular trafficking. However, all these data were derived from studies using herpes simplex virus type 1 (HSV-1) and may not apply to VP22 homologs of other alphaherpesviruses. We compared subcellular attributes of HSV-1 VP22 (HVP22) with bovine herpesvirus 1 (BHV-1) VP22 (BVP22) using green fluorescent protein (GFP)-fused VP22 expression vectors. Fluorescence microscopy of cell lines transfected with these constructs revealed differences as well as similarities between the two VP22 homologs. Compared to that of HVP22, the BVP22 microtubule interaction was much less pronounced. The VP22 nuclear interaction varied, with a marbled or halo appearance for BVP22 and a speckled or nucleolus-bound appearance for HVP22. Both VP22 homologs associated with chromatin at various stages of mitosis and could traffic from expressing cells to the nuclei of nonexpressing cells. However, distinct qualitative differences in microtubule, nuclear, and chromatin association as well as trafficking were observed. The differences in VP22 homolog characteristics revealed in this study will help define VP22 function within HSV-1 and BHV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708447      PMCID: PMC111831          DOI: 10.1128/jvi.74.7.3301-3312.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  29 in total

1.  Overexpression of the herpes simplex virus type 1 tegument protein VP22 increases its incorporation into virus particles.

Authors:  J Leslie; F J Rixon; J McLauchlan
Journal:  Virology       Date:  1996-06-01       Impact factor: 3.616

2.  Role of herpes simplex virus type 1 UL46 and UL47 in alpha TIF-mediated transcriptional induction: characterization of three viral deletion mutants.

Authors:  Y Zhang; D A Sirko; J L McKnight
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

3.  Intercellular trafficking and protein delivery by a herpesvirus structural protein.

Authors:  G Elliott; P O'Hare
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

4.  Phosphorylation of the herpes simplex virus type 1 tegument protein VP22.

Authors:  G Elliott; D O'Reilly; P O'Hare
Journal:  Virology       Date:  1996-12-01       Impact factor: 3.616

5.  The bovine herpesvirus type 1 major tegument protein VP8 expressed in recombinant vaccinia virus does not induce significant immunity in mice.

Authors:  S LaBoissière; M Trudel; C Simard
Journal:  Virus Res       Date:  1996-02       Impact factor: 3.303

6.  Modified VP22 localizes to the cell nucleus during synchronized herpes simplex virus type 1 infection.

Authors:  L E Pomeranz; J A Blaho
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

7.  Differential control of transcription by homologous homeodomain coregulators.

Authors:  C C Huang; W Herr
Journal:  Mol Cell Biol       Date:  1996-06       Impact factor: 4.272

8.  The role of the major tegument protein VP8 of bovine herpesvirus-1 in infection and immunity.

Authors:  S van Drunen Littel-van den Hurk; S Garzon; J V van den Hurk; L A Babiuk; P Tijssen
Journal:  Virology       Date:  1995-01-10       Impact factor: 3.616

9.  Redistribution of microtubules and Golgi apparatus in herpes simplex virus-infected cells and their role in viral exocytosis.

Authors:  E Avitabile; S Di Gaeta; M R Torrisi; P L Ward; B Roizman; G Campadelli-Fiume
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

10.  Characterization of bovine herpesvirus 1 UL49 homolog gene and product: bovine herpesvirus 1 UL49 homolog is dispensable for virus growth.

Authors:  X Liang; B Chow; Y Li; C Raggo; D Yoo; S Attah-Poku; L A Babiuk
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  22 in total

Review 1.  Herpesvirus assembly and egress.

Authors:  Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Characterization of Marek's disease virus serotype 1 (MDV-1) deletion mutants that lack UL46 to UL49 genes: MDV-1 UL49, encoding VP22, is indispensable for virus growth.

Authors:  Fabien Dorange; B Karsten Tischer; Jean-François Vautherot; Nikolaus Osterrieder
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

3.  Herpes simplex virus tegument protein VP22 contains overlapping domains for cytoplasmic localization, microtubule interaction, and chromatin binding.

Authors:  Ana Martin; Peter O'Hare; John McLauchlan; Gillian Elliott
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Assembly of infectious Herpes simplex virus type 1 virions in the absence of full-length VP22.

Authors:  L E Pomeranz; J A Blaho
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

Review 5.  Enhancing DNA vaccine potency by modifying the properties of antigen-presenting cells.

Authors:  Shaw-Wei D Tsen; Augustine H Paik; Chien-Fu Hung; T-C Wu
Journal:  Expert Rev Vaccines       Date:  2007-04       Impact factor: 5.217

6.  Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen.

Authors:  W F Cheng; C H Hung; C Y Chai; K F Hsu; L He; M Ling; T C Wu
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle.

Authors:  Chunfu Zheng; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

8.  The varicella-zoster virus (VZV) ORF9 protein interacts with the IE62 major VZV transactivator.

Authors:  Cristian Cilloniz; Wallen Jackson; Charles Grose; Donna Czechowski; John Hay; William T Ruyechan
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

Review 9.  DNA vaccines for cervical cancer: from bench to bedside.

Authors:  Chien-Fu Hung; Archana Monie; Ronald D Alvarez; T-C Wu
Journal:  Exp Mol Med       Date:  2007-12-31       Impact factor: 8.718

10.  Physical interaction between envelope glycoproteins E and M of pseudorabies virus and the major tegument protein UL49.

Authors:  Walter Fuchs; Barbara G Klupp; Harald Granzow; Christoph Hengartner; Alexandra Brack; Alice Mundt; Lynn W Enquist; Thomas C Mettenleiter
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.